COMMUNIQUÉS West-GlobeNewswire

Palvella Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
13/10/2026
WAYNE, Pa., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (Palvella or the “Company”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies [...]
Trevi Therapeutics Announces Oral Presentation Accepted at the CHEST 2026 Annual Meeting
13/10/2026
Professor Philip Molyneaux will present on the patient-reported outcomes from the Phase 2b CORAL trial of nalbuphine ER for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) NEW HAVEN, [...]
Repligen to Report Third Quarter 2026 Financial Results
13/10/2026
Webcast and Conference Call to Be Held Tuesday, October 27, 2026, at 8:00 a.m. ET WALTHAM, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), today announced that the Company will report its [...]
BrainsWay Reports Rise in Favorable Accelerated Deep TMS™ Coverage to Over 70 Million Covered Lives
13/10/2026
BURLINGTON, Mass. and JERUSALEM, Oct. 13, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today [...]
Fan-Favorite and Limited-Edition Spinach® Green Apple-Flavored Products are Returning for the Fall Season
13/10/2026
TORONTO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, announced today that for the third consecutive year it is bringing back its [...]
Intellia Therapeutics Appoints Jing L. Marantz, M.D., Ph.D., as Chief Medical Officer
13/10/2026
CAMBRIDGE, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core [...]
CG Oncology Appoints Proven Biopharmaceutical Commercial Leader Isabel Kalofonos as Chief Commercial Officer
13/10/2026
DALLAS, Oct. 13, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today announced the appointment of Isabel Kalofonos as Chief Commercial Officer. A highly accomplished biopharmaceutical executive with more [...]
From Ocean to Animal Well-Being: Acadian Launches Tasco® Optimized Feed Technology Designed to Boost Resilience and Productivity
13/10/2026
DARTMOUTH, Nova Scotia, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Acadian Animal Wellness today announced the global launch of Tasco® optimized feed technology for use in animal feed products. Derived from Ascophyllum nodosum [...]
Daxor to Showcase Blood Volume Analysis Platform at ASN Kidney Week 2026
13/10/2026
Making its ASN debut, Daxor’s BVA ™ technology delivers precise volume measurement to optimize fluid management and improve complex kidney care. Key Highlights: Commercial Presence: Daxor exhibiting at Booth #390 during [...]
Diverge Health Merges with Medical Home Network to Strengthen Value-Based Care for Safety-Net Providers and Patients
13/10/2026
The combined company is creating a new standard to drive better outcomes for providers dedicated to under-resourced communities CHICAGO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Diverge Health , an organization that partners [...]
Alignment Health Expands Medicare Advantage Coverage to Four New Charlotte-Area Counties for 2027
13/10/2026
Expansion brings Alignment's coordinated care model, access to Novant Health and Tryon Medical Partners, and new Medicare Advantage plan options to more than 295,000 additional Medicare beneficiaries CHARLOTTE, N.C., [...]
Reflect Scientific Introduces PF-90 Blast Plate Freezer, Combining Two Freezing Technologies for Biopharmaceutical and Cell Therapy Applications
13/10/2026
OREM, Utah, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), through its Cryometrix brand, today announced the launch of the PF-90 Blast Plate Freezer, a next-generation ultra-low temperature [...]
MediPharm Labs Expands Its International Medical Cannabis Footprint with First CBD Metered-Dose Inhaler Shipment to Panama
13/10/2026
MediPharm has completed its first shipment to Adeiwa Pharma, which will distribute the product to patients in Panama. TORONTO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ [...]
Shattuck Labs Announces Two Poster Presentations at UEG Week 2026
13/10/2026
AUSTIN, Texas and DURHAM, N.C., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potential first-in- [...]
Novastra Therapeutics to Present Initial Phase 1 Data for OAP-101 in Anti–PD-1–Refractory Advanced Melanoma at ESMO Congress 2026
13/10/2026
First clinical data for OAP-101, built on proprietary OmniAntigen™ Platform (OAP) OAP enables systematic immune reprogramming therapy (XIRT™) to overcome resistance of cold solid tumors to current therapies, including [...]
Tenvie Therapeutics Announces First Subject Dosed in Phase 1 Trial of TNV313, Expanding Its Fully CNS-Penetrant NLRP3 Franchise
13/10/2026
Third drug candidate from Tenvie’s product engine to enter clinical development in 2026 TNV313 joins TNV262 to give Tenvie two clinical-stage, fully CNS-penetrant NLRP3 inhibitors, enabling parallel development across [...]
Mesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million in Profitable Growth
13/10/2026
The Restructuring Program focuses Clinical Genomics on profitability and adds resources in Sterilization and Disinfection Control, Calibration Solutions and Asia LAKEWOOD, Colo., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Mesa [...]
Immutep Regains Compliance with Nasdaq Minimum Bid Price Requirement
13/10/2026
SYDNEY, AUSTRALIA, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep" or "the Company"), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announced [...]
MBX Biosciences to Participate in Upcoming November Investor Conferences
13/10/2026
CARMEL, Ind. and BURLINGTON, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel [...]

Pages